IN2015DN00515A - - Google Patents
Info
- Publication number
- IN2015DN00515A IN2015DN00515A IN515DEN2015A IN2015DN00515A IN 2015DN00515 A IN2015DN00515 A IN 2015DN00515A IN 515DEN2015 A IN515DEN2015 A IN 515DEN2015A IN 2015DN00515 A IN2015DN00515 A IN 2015DN00515A
- Authority
- IN
- India
- Prior art keywords
- microglobulin
- alpha
- treatment
- relates
- present
- Prior art date
Links
- 102000003966 Alpha-1-microglobulin Human genes 0.000 abstract 1
- 101800001761 Alpha-1-microglobulin Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000003470 mitochondria Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1722—Plasma globulins, lactoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201270538 | 2012-09-05 | ||
| DKPA201270557 | 2012-09-12 | ||
| PCT/EP2013/068270 WO2014037390A1 (fr) | 2012-09-05 | 2013-09-04 | Alpha-1-microglobuline destinée à être utilisée dans le traitement de maladies associées aux mitochondries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN00515A true IN2015DN00515A (fr) | 2015-06-26 |
Family
ID=49162118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN515DEN2015 IN2015DN00515A (fr) | 2012-09-05 | 2013-09-04 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10226507B2 (fr) |
| EP (1) | EP2900254B1 (fr) |
| JP (2) | JP2015533790A (fr) |
| KR (1) | KR20150047510A (fr) |
| CN (1) | CN104661673A (fr) |
| AU (1) | AU2013311714C1 (fr) |
| BR (1) | BR112015003957A2 (fr) |
| CA (1) | CA2881321A1 (fr) |
| DK (1) | DK2900254T3 (fr) |
| EA (1) | EA028963B1 (fr) |
| ES (1) | ES2599034T3 (fr) |
| HR (1) | HRP20161364T1 (fr) |
| HU (1) | HUE030559T2 (fr) |
| IN (1) | IN2015DN00515A (fr) |
| MX (1) | MX357656B (fr) |
| NZ (1) | NZ629621A (fr) |
| PL (1) | PL2900254T3 (fr) |
| PT (1) | PT2900254T (fr) |
| SG (1) | SG11201500669SA (fr) |
| WO (1) | WO2014037390A1 (fr) |
| ZA (1) | ZA201500547B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016204360A (ja) * | 2015-02-25 | 2016-12-08 | エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ | 放射性核種療法における腎臓の保護に用いるためのアルファ−１−ミクログロブリン |
| WO2017144674A1 (fr) * | 2016-02-25 | 2017-08-31 | A1M Pharma Ab | Alpha-1-microglobuline pour utilisation dans la protection des reins en relation avec l'utilisation de produits de contraste |
| AU2017235608B2 (en) * | 2016-03-18 | 2020-10-22 | Guard Therapeutics International AB | Novel alpha-1-microglobulin derived proteins and their use |
| GB2566516A (en) | 2017-09-15 | 2019-03-20 | Univ Oxford Innovation Ltd | Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria |
| CN109867717A (zh) * | 2019-04-01 | 2019-06-11 | 山西瑞亚力生物技术有限公司 | 一种血浆中α1微球蛋白的提取方法 |
| CN110452980B (zh) * | 2019-09-23 | 2023-07-28 | 武汉儿童医院 | 一种线粒体脑肌病诊断试剂盒及应用 |
| US20220362293A1 (en) * | 2019-09-25 | 2022-11-17 | Cytegen Corp. | Treatment of Mitochondrial Deficits and Age-Related Diseases Using Blood Products |
| CN115575646B (zh) * | 2022-11-21 | 2023-04-28 | 四川大学华西医院 | 一种代谢标志物组在制备预测癫痫发作的试剂盒中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005051379A1 (fr) * | 2003-11-26 | 2005-06-09 | Sanofi-Aventis Deutschland Gmbh | Proteinurie tubulaire utile comme indicateur de risques cardio-vasculaires eleves |
| EA031877B1 (ru) * | 2007-02-12 | 2019-03-29 | А1М Фарма Аб | Применение альфа-1-микроглобулина для профилактики или лечения преэклампсии |
| DK2300614T3 (en) * | 2008-02-04 | 2016-02-08 | Yissum Res Dev Co | METHODS AND COMPOSITIONS FOR THE TREATMENT OF mitochondrial |
| HUE030274T2 (en) * | 2008-07-18 | 2017-05-29 | A1M Pharma Ab | The therapeutic use of the root binding and antioxidant alpha-1 microglobulin |
-
2013
- 2013-09-04 IN IN515DEN2015 patent/IN2015DN00515A/en unknown
- 2013-09-04 CA CA2881321A patent/CA2881321A1/fr not_active Abandoned
- 2013-09-04 SG SG11201500669SA patent/SG11201500669SA/en unknown
- 2013-09-04 DK DK13759995.7T patent/DK2900254T3/en active
- 2013-09-04 US US14/423,260 patent/US10226507B2/en not_active Expired - Fee Related
- 2013-09-04 EP EP13759995.7A patent/EP2900254B1/fr not_active Not-in-force
- 2013-09-04 CN CN201380043567.0A patent/CN104661673A/zh active Pending
- 2013-09-04 ES ES13759995.7T patent/ES2599034T3/es active Active
- 2013-09-04 JP JP2015530375A patent/JP2015533790A/ja active Pending
- 2013-09-04 PT PT137599957T patent/PT2900254T/pt unknown
- 2013-09-04 HU HUE13759995A patent/HUE030559T2/en unknown
- 2013-09-04 EA EA201590503A patent/EA028963B1/ru not_active IP Right Cessation
- 2013-09-04 WO PCT/EP2013/068270 patent/WO2014037390A1/fr active Application Filing
- 2013-09-04 NZ NZ629621A patent/NZ629621A/en not_active IP Right Cessation
- 2013-09-04 HR HRP20161364TT patent/HRP20161364T1/hr unknown
- 2013-09-04 PL PL13759995T patent/PL2900254T3/pl unknown
- 2013-09-04 MX MX2015002604A patent/MX357656B/es active IP Right Grant
- 2013-09-04 KR KR1020157005748A patent/KR20150047510A/ko not_active Ceased
- 2013-09-04 BR BR112015003957A patent/BR112015003957A2/pt not_active Application Discontinuation
- 2013-09-04 AU AU2013311714A patent/AU2013311714C1/en not_active Ceased
-
2015
- 2015-01-23 ZA ZA2015/00547A patent/ZA201500547B/en unknown
-
2018
- 2018-08-24 JP JP2018157394A patent/JP2018203756A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201500547B (en) | 2017-09-27 |
| US10226507B2 (en) | 2019-03-12 |
| HRP20161364T1 (hr) | 2016-12-16 |
| MX357656B (es) | 2018-07-18 |
| HUE030559T2 (en) | 2017-05-29 |
| PT2900254T (pt) | 2016-10-18 |
| AU2013311714A1 (en) | 2015-03-12 |
| JP2018203756A (ja) | 2018-12-27 |
| EP2900254A1 (fr) | 2015-08-05 |
| WO2014037390A1 (fr) | 2014-03-13 |
| US20150258171A1 (en) | 2015-09-17 |
| AU2013311714B2 (en) | 2017-10-12 |
| PL2900254T3 (pl) | 2017-02-28 |
| HK1210585A1 (en) | 2016-04-29 |
| JP2015533790A (ja) | 2015-11-26 |
| MX2015002604A (es) | 2015-06-10 |
| EP2900254B1 (fr) | 2016-08-03 |
| DK2900254T3 (en) | 2016-08-29 |
| CA2881321A1 (fr) | 2014-03-13 |
| ES2599034T3 (es) | 2017-01-31 |
| BR112015003957A2 (pt) | 2017-08-08 |
| CN104661673A (zh) | 2015-05-27 |
| KR20150047510A (ko) | 2015-05-04 |
| EA028963B1 (ru) | 2018-01-31 |
| AU2013311714C1 (en) | 2018-01-25 |
| SG11201500669SA (en) | 2015-02-27 |
| EA201590503A1 (ru) | 2015-06-30 |
| NZ629621A (en) | 2015-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN00515A (fr) | ||
| EP2932930A4 (fr) | Instrument de traitement | |
| MX356728B (es) | Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2. | |
| HUE056006T2 (hu) | Kombináció Parkinson-kór kezelésére | |
| SG11201509012QA (en) | Sobetirome in the treatment of myelination diseases | |
| MX2021004211A (es) | Composiciones vacuna. | |
| MX349224B (es) | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa. | |
| AP2014007399A0 (en) | Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament | |
| RS53893B1 (en) | USE OF BIOTIN FOR MULTIPLE SCLEROSIS TREATMENT | |
| IL235429A0 (en) | (r)-nifortal, its use in the treatment of infections and the preparation of (r) and (s)-nifortal | |
| GB201511770D0 (en) | Novel pharmaceutical formulationsand their use in the treatment of periodontal disease | |
| EP2825194A4 (fr) | Utilisation d'antithrombine dans le traitement de la pré-éclampsie | |
| GB2518801B (en) | Improvements in, or relating to, caskets or coffins | |
| EP2767214A4 (fr) | Instrument de traitement | |
| UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
| IN2014KN01772A (fr) | ||
| IL234494B (en) | Composition for the treatment of menopausal symptoms | |
| BR112015023730A2 (pt) | uso de sedoeptulose como suplemento nutricional | |
| ZA201500652B (en) | Medicine againts gastroesephageal reflux disease | |
| CY1117740T1 (el) | Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης | |
| GB201310748D0 (en) | Student's clinic | |
| UA24322S (uk) | Стамеска пасічника | |
| FI20115180L (fi) | Koostumus käytettäväksi sairauden hoidossa | |
| UA75904U (xx) | Стоматологічний комплект "sadaf dent streg" | |
| UA80618U (en) | Use of n-steroylethanolamine as radiomodifier |